HUTCHMED (China) Limited (HCM)
Nasdaq: HCM · Pharmaceutical Preparations · Hong Kong · filing with the SEC since 2015
Who runs HUTCHMED (China) Limited
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Cheng Chig Fung
Acting CEO and CFO. First filing Mar 2026, latest May 21, 2026, 0 filings in all.
Officers reporting now
4
of 12 people with a filing in the last fifteen months
Directors reporting now
8
12 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Cheng Chig Fung | Acting CEO and CFO | Mar 2026 | May 21, 2026 | none |
| Su Wei-Guo | CEO and CSO | Mar 2026 | May 21, 2026 | none |
| Chiu Lorenso | Deputy Chief Financial Officer | Mar 2026 | May 21, 2026 | none |
| Nixon Charles George Rupert | Group General Counsel | Mar 2026 | May 21, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Mok Tony Shu Kam | director | Mar 2026 | May 13, 2026 | none |
| Bhatia Renu | director | Mar 2026 | Mar 10, 2026 | none |
| Eldar Dan | director | Mar 2026 | Mar 10, 2026 | none |
| Hu Chaohong | director | Mar 2026 | Mar 10, 2026 | none |
| Shih Edith | director | Mar 2026 | Mar 10, 2026 | none |
| Tan Daniel Shao Weng | director | Mar 2026 | Mar 10, 2026 | none |
| Wong Tak Wai | director | Mar 2026 | Mar 10, 2026 | none |
| Yang Ling | director | Mar 2026 | Mar 10, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.